|Other Names||Uridine-cytidine kinase-like 1, UCKL1, URKL1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP7193a was selected from the N-term region of human URKL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May contribute to UTP accumulation needed for blast transformation and proliferation.|
|Cellular Location||Cytoplasm. Nucleus. Note=EBNA3 induces isoform 1 translocation to the nucleus, whereas it does change isoform 3 location|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Uridine kinase is a key enzyme in the pyrimidine salvage pathway of all mammalian cells. URKL1 (uridine kinase-like 1) is highly similar in structure and sequence to uridine kinase.
Kashuba, E., et al., (er) BMC Cell Biol. 3 (1), 23 (2002) (): ().
If you have any additional inquiries please email technical services at email@example.com.